Corrigendum to “Occurrence of infection following prostate biopsy procedures in Japan: Japanese Research Group for Urinary Tract Infection (JRGU) – A multi-center retrospective study” [J Infect Chemother 20 (2014) 232–237]

Togo, Yoshikazu; Kubo, Toshikazu; Taoka, Rikiya; Hiyama, Yoshiki; Uehara, Teruhisa; Hashimoto, Jiroh; Kurimura, Yuichiro; Takahashi, Satoshi; Tsukamoto, Taiji; Miyazaki, Jun; Nishiyama, Hiroyuki; Kira, Shintaro; Kiyota, Hiroshi; Yazawa, Satoshi; Niwa, Naoya; Hongo, Hiroshi; Oya, Mototsugu; Kato, Taku; Yasuda, Mitsuru; Deguchi, Takashi; Ishikawa, Kiyohito; Hoshinaga, Kiyotaka; Matsumoto, Minori; Shigemura, Katsumi; Tanaka, Kazushi; Arakawa, Soichi; Fujisawa, Masato; Wada, Koichiro; Uehara, Shuichiro; Watanabe, Tetsu; Kumon, Hiromi; Kobayashi, Kanao; Matsubara, Akio; Matsumoto, Masahiro; Sho, Takehiko; Hamasuna, Ryoichi; Matsumoto, Tetsuro; Hayami, Hiroshi; Nakagawa, Masayuki; Yamamoto, Shingo

doi:10.1016/j.jiac.2014.07.009

Cited by 11 publications

(26 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…TRUS prostate biopsy is widely used to diagnose prostate cancer. In a multicenter study in Japan, 73.8% of men with suspicion of prostate cancer were reported to have undergone TRUS prostate biopsy, while the remainder had transperineal prostate biopsy . The frequency of infective complications was reported to be 0.83% in Japan.…”

Section: Introductionmentioning

confidence: 99%

Selective culture of Escherichia coli to prevent infective complications of transrectal ultrasound‐guided prostate biopsy: Clinical efficacy and analysis of characteristics of quinolone‐resistant Escherichia coli

et al. 2019

Self Cite

View full text Add to dashboard Cite

Objectives To evaluate a regimen of targeted prophylaxis using rectal swab culture in patients undergoing transrectal ultrasound‐guided prostate biopsy, and to investigate the characteristics of isolated fluoroquinolone‐resistant Escherichia coli. Methods A prospective study was carried out from June 2013 through December 2014. Rectal swabs were cultured on agar plates containing either 2 μg/mL levofloxacin or 1 μg/mL sitafloxacin before transrectal ultrasound‐guided prostate biopsy. Patients with susceptible organisms received levofloxacin or sitafloxacin, whereas those with resistant organisms received directed antimicrobial prophylaxis according to the results of the antimicrobial susceptibility test. Patients with infectious complications after prostate biopsy were identified, and characteristics of patients carrying fluoroquinolone‐resistant Escherichia coli were analyzed. Results A total of 397 men underwent transrectal ultrasound‐guided prostate biopsy. Of these patients, 74 (18.6%) had fluoroquinolone‐resistant Escherichia coli. All fluoroquinolone‐resistant Escherichia coli were susceptible to amikacin and meropenem. The risk factor for possible fluoroquinolone‐resistant Escherichia coli was age of ≥73 years. Three (0.7%) patients who received appropriate antimicrobial prophylaxis had high‐grade fever after the prostate biopsy. However, the pathogens were not fluoroquinolone‐resistant Escherichia coli. Conclusions Targeted antimicrobial prophylaxis in patients undergoing transrectal ultrasound‐guided prostate biopsy can be associated with reducing severe infectious complications caused by fluoroquinolone‐resistant Escherichia coli.

show abstract

Section: Introductionmentioning

confidence: 99%

Selective culture of Escherichia coli to prevent infective complications of transrectal ultrasound‐guided prostate biopsy: Clinical efficacy and analysis of characteristics of quinolone‐resistant Escherichia coli

et al. 2019

Self Cite

View full text Add to dashboard Cite

show abstract

“…More than 10 years ago, a single 500‐mg dose of oral levofloxacin was reported to be effective and safe for low‐risk patients . As noted above, a retrospective multicenter study carried out in Japan found no significant difference in the infection rate between patients given a single dose of quinolone antibiotics as compared with those administered for ≥2 days, at least in low‐risk cases . As in Western guidelines, those presented in Japan note that a single administration of quinolone antibiotics is recommended.…”

Section: Transrectal Approachmentioning

confidence: 98%

“…Furthermore, several studies of quinolone antimicrobial administration duration for prophylaxis before a transrectal prostate biopsy divided their patients into 1‐ and 3‐day groups, though none found a difference in regard to infection rate . The occurrence of infection after a prostate biopsy procedure was also investigated in a multicenter retrospective study by the JRGU . Among patients who underwent a rectal prostate biopsy, 365 were given a single dose (500 mg) and 386 were given multiple doses of levofloxacin.…”

Section: Transrectal Approachmentioning

confidence: 99%

Prevention of infectious complications after prostate biopsy procedure

Togo

Yamamoto

2017

Int J of Urology

Self Cite

View full text Add to dashboard Cite

Although febrile complications are rarely encountered after a prostate biopsy procedure, in recent years the number of cases of fatal infection after that have increased along with increases in resistant bacteria. The available biopsy approaches are transrectal and transperineal, with the transrectal approach primarily used. As the invasion path of the puncture needle differs between these approaches, pretreatment and the method of administration of preventive antimicrobial drugs should be separately considered for infection prevention. Recently, the Japanese guidelines for perioperative infection prevention in the field of urology were revised after receiving approval from the Japanese Urological Association. With use of the transrectal approach, attempts have been made to selectively administer prophylactic antibiotics by confirming the presence or absence of resistant bacteria in rectal swab culture results before carrying out a prostate biopsy procedure because of potential problems associated with resistant bacteria in rectal flora. For preventive antibiotics, a single dose of oral quinolone is recommended for patients with low risk, whereas daily administrations of piperacillin/ tazobactam are recommended for those considered to be high risk. In contrast, for the transperineal procedure, a single dose of oral quinolone is recommended as a preventive antibiotic. With both approaches, it is important to empirically administer broad-spectrum antimicrobials when occurrence of a febrile infection after a prostate biopsy procedure is confirmed.

show abstract

“…The Japanese study was based on a retrospective review of case notes from 212 065 procedures carried out between 2004 and 2006, and found that 1.1% and 0.07% of the patients had fever and sepsis, respectively . Our group also retrospectively investigated the incidence of genitourinary tract infection in 5895 patients who underwent a transrectal and/or transperineal prostate biopsy between January and December 2011 at 46 institutions belonging to the Japanese Research Group for Urinary Tract Infection . Univariate analysis results showed older age ( P = 0.015) and avoidance of disinfection in the rectum ( P = 0.0001) as possible factors for infection with the transrectal approach, whereas an indwelling urethral catheter ( P < 0.001), use of immunosuppressive agents ( P = 0.009) and steroid administration ( P < 0.001) were candidates with the transperineal approach.…”

mentioning

confidence: 99%

“…Third, a transperineal approach might offer an alternative method for obtaining prostate tissue samples. Although it is not routinely carried out worldwide, this procedure is executed in one‐quarter of the institutions in Japan . Kakehi et al .…”

mentioning

confidence: 99%

Editorial Comment from Dr Togo to Hospital admissions after transrectal ultrasound‐guided biopsy of the prostate in men diagnosed with prostate cancer: A database analysis in England

Togo

2014

Int J of Urology

Self Cite

View full text Add to dashboard Cite

A prostate biopsy procedure is indispensable for detection of prostate cancer, and the transrectal approach is carried out worldwide. Although genitourinary tract infections after a prostate biopsy are infrequent, antimicrobial prophylaxis is given when appropriate, as an increase in incidence of febrile infection with resistant organisms after such procedure has been reported, with profound clinical and economic impacts. In addition, potentially fatal infective complications including septic shock after a prostate biopsy procedure have also been documented. This is a large retrospective study that investigated the complication rate and analyzed risk factors after transrectal prostate biopsy procedure carried out in England.1 The study findings are interesting in this era of increasing multidrug-resistant bacterial infections, and might influence clinical practice.The present study is similar to a Japanese study that has been reported in International Journal of Urology. The Japanese study was based on a retrospective review of case notes from 212 065 procedures carried out between 2004 and 2006, and found that 1.1% and 0.07% of the patients had fever and sepsis, respectively.2 Our group also retrospectively investigated the incidence of genitourinary tract infection in 5895 patients who underwent a transrectal and/or transperineal prostate biopsy between January and December 2011 at 46 institutions belonging to the Japanese Research Group for Urinary Tract Infection.3 Univariate analysis results showed older age (P = 0.015) and avoidance of disinfection in the rectum (P = 0.0001) as possible factors for infection with the transrectal approach, whereas an indwelling urethral catheter (P < 0.001), use of immunosuppressive agents (P = 0.009) and steroid administration (P < 0.001) were candidates with the transperineal approach. In contrast, multivariate analysis showed no risk factors for infectious complications after a prostate biopsy with either approach. Hospitalization was required in 0.63% of those cases (transrectal 0.73%, transperineal 0.24%).There has been a recent increase in multidrug-resistant pathogens, which is a serious problem, and recent studies have highlighted four approaches that can be used to prevent infection after a prostate biopsy.First is careful objective determination of patients who require a transrectal ultrasound-guided biopsy of the prostate procedure. Nomograms and predictive models, new biomarkers and derivatives of prostate-specific antigen, as well as the newly employed multiparametric magnetic resonance imaging, are helpful for selecting patients at increased risk of prostate cancer, as an unnecessary prostate biopsy procedure must be avoided in those cases. 4 Second, routine rectal swab culture findings can indicate the need for prophylactic antibiotics by characterization of antimicrobial resistance in the rectal flora, though its cost might not be covered by insurance in several countries. Taylor et al. reported that targeted antimicrobial prophylaxis based on the results of...

show abstract

Corrigendum to “Occurrence of infection following prostate biopsy procedures in Japan: Japanese Research Group for Urinary Tract Infection (JRGU) – A multi-center retrospective study” [J Infect Chemother 20 (2014) 232–237]

Cited by 11 publications

References 0 publications

Selective culture of Escherichia coli to prevent infective complications of transrectal ultrasound‐guided prostate biopsy: Clinical efficacy and analysis of characteristics of quinolone‐resistant Escherichia coli

Selective culture of Escherichia coli to prevent infective complications of transrectal ultrasound‐guided prostate biopsy: Clinical efficacy and analysis of characteristics of quinolone‐resistant Escherichia coli

Prevention of infectious complications after prostate biopsy procedure

Editorial Comment from Dr Togo to Hospital admissions after transrectal ultrasound‐guided biopsy of the prostate in men diagnosed with prostate cancer: A database analysis in England

Contact Info

Product

Resources

About